Former Lawyer Went From $50K To $5.3M Trading Options
Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.

I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).

I grew my $50K into $5.3M
I'll show you how I did it here.

ATX Insider Trading (Amplia Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$240,617.17
Insider Selling (Last 12 Months): A$0.00

Amplia Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Amplia Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amplia Therapeutics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for ATX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Better Options For Trading!
I know–you’ve heard options trading is tough, but is it really tougher than the market is right now?

NO! “Options Trading Made Easy” by pro-trader Chuck Hughes gives traders the best options in an unpredictable market…

Get your copy now!

Amplia Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/10/2022S Jane BellInsiderBuy127,136A$0.17A$21,613.12
12/20/2021S Jane BellInsiderBuy714,285A$0.15A$103,571.33
9/2/2021Jane BellInsiderBuy557,646A$0.21A$115,432.72
6/7/2021John LambertInsiderExercise130,000A$0.16A$20,150.00
9/18/2020Robert PeachInsiderIssued275,808A$0.13A$35,027.62
8/4/2020John LambertInsiderIssued120,000A$0.10A$12,000.00
7/13/2020Warwick TongInsiderIssued200,000A$0.10A$20,000.00
9/17/2019Robert PeachInsiderTransfer56,000A$0.08A$4,480.00
8/2/2019Andrew CookeInsiderIssued63A$0.10A$5.99
See Full Table
This Options Expert is Giving Everything Away!
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you!

His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
Get your copy today!

SEC Filings (Institutional Ownership Changes) for Amplia Therapeutics (ASX:ATX)

Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for cancer and fibrotic disease indication. It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Read More on Amplia Therapeutics

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


77,249 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Amplia Therapeutics?

Amplia Therapeutics' top insider investors include:
  1. Jane Bell (Insider)
  2. John Lambert (Insider)
  3. Robert Peach (Insider)
  4. S Jane Bell (Insider)
  5. Warwick Tong (Insider)
Learn More about top insider investors at Amplia Therapeutics.
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.